Global In Vivo Imaging Solutions Market Growth (Status and Outlook) 2024-2030

Global In Vivo Imaging Solutions Market Growth (Status and Outlook) 2024-2030

In vivo imaging is the non-invasive visualization of living organisms for research or diagnostic purposes. Generally speaking, this method can be divided in two key areas: anatomical/morphological imaging and molecular imaging. In molecular imaging cellular function or molecular processes are visualized, normally using biomarkers. While in anatomical imaging no marker is used and visualization is based on the intrinsic properties of the tissues and organs being observed, such as the attenuation of X-rays in the case of computed tomography, molecular imaging very often uses biomarkers labeled with bioluminescence or fluorescence.

The global In Vivo Imaging Solutions market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “In Vivo Imaging Solutions Industry Forecast” looks at past sales and reviews total world In Vivo Imaging Solutions sales in 2022, providing a comprehensive analysis by region and market sector of projected In Vivo Imaging Solutions sales for 2023 through 2029. With In Vivo Imaging Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vivo Imaging Solutions industry.

This Insight Report provides a comprehensive analysis of the global In Vivo Imaging Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vivo Imaging Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vivo Imaging Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vivo Imaging Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vivo Imaging Solutions.

United States market for In Vivo Imaging Solutions is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for In Vivo Imaging Solutions is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for In Vivo Imaging Solutions is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key In Vivo Imaging Solutions players cover Revvity, Berthold Technologies, Analytik Jena, Azure Biosystems, LICORBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vivo Imaging Solutions market by product type, application, key players and key regions and countries.

Segmentation by Type:

In Vivo Imaging Instruments

In Vivo Imaging Reagents

In Vivo Imaging Software

In Vivo Imaging Accessories

Segmentation by Application:

Laboratories

Vet Hospitals and Clinics

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:

In Vivo Imaging Instruments

In Vivo Imaging Reagents

In Vivo Imaging Software

In Vivo Imaging Accessories

Segmentation by Application:

Laboratories

Vet Hospitals and Clinics

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Revvity

Berthold Technologies

Analytik Jena

Azure Biosystems

LICORBio

Scintica Instrumentation

Vieworks

Thermo Fisher Scientific

Ningbo Icoe Commodity

Canon Medical Systems

Bruker

Hallmarq Veterinary Imaging

Huan Tong Nuclear Magnetic

Sunny Optical Technology

Photon

MILABS

iThera Medical

Aspect Imaging

TOMOWAVE

Trifoil Imaging

Clinx

Raylight Technology

Beijing NOVEL MEDICAL Equipmen

Tanon

Guangzhou Biolight Biotechnology

PINGSENG Healthcare

Fujifilm Visualsonics

Please note: The report will take approximately 2 business days to prepare and deliver.